WBO:BIO's Gross Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 26.36 * Ranked among companies with meaningful Gross Margin % only.
Biogena Group Invest AG had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Biogena Group Invest AG was 0.00% per year.
Biogena Group Invest AG (WBO:BIO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Biogena Group Invest AG had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Biogena Group Invest AG Gross Margin % Related Terms
Biogena Group Invest AG Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:BIO vs KHC, GIS, HRL: Gross Margin % Comparison
For the Packaged Foods subindustry, Biogena Group Invest AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Biogena Group Invest AG (WBO:BIO) has a Gross Margin % of 0.00% as of Jan. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Biogena Group Invest AG and its competitors. Over the past decade, Biogena Group Invest AG's Gross Margin % has ranged from 99.40 to 99.70. According to the industry distribution chart, Biogena Group Invest AG ranks #999999 out of 1899 companies in the Consumer Packaged Goods industry.
Is Biogena Group Invest AG's Gross Margin % too high?
Biogena Group Invest AG's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 99.40 to a high of 99.70. Based on the distribution chart, Biogena Group Invest AG ranks #999999 out of 1899 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Biogena Group Invest AG has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Gross Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biogena Group Invest AG ranks #999999 out of 1899 companies for Gross Margin %. This places Biogena Group Invest AG in the lower half of its industry. The industry median Gross Margin % is 26.36. Historically, Biogena Group Invest AG's own Gross Margin % has ranged from 99.40 to 99.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.36, based on 1,899 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Biogena Group Invest AG and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogena Group Invest AG's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.46, compared to a current price of €4.50 — trading 30.1% above its estimated fair value. The current Gross Margin % is 0.00%. Biogena Group Invest AG's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Gross Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €4.50 is trading 30.1% above its estimated GF Value™ of €3.46.
GuruFocus considers Biogena Group Invest AG to be Modestly Overvalued.
Key valuation signals for WBO:BIO:
Gross Margin %: 0.00%
GF Value™: €3.46 vs. price of €4.50 (30.1% above fair value)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
64GF Score
Get the complete analysis for WBO:BIO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 